These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33598084)

  • 21. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
    Choe EY; Lee YH; Choi YJ; Huh BW; Lee BW; Kim SK; Kang ES; Cha BS; Lee EJ; Huh KB; Younossi ZM
    J Gastroenterol Hepatol; 2018 May; 33(5):1082-1091. PubMed ID: 28990251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.
    Hwang SM; Cho KY
    Eur Radiol; 2023 Nov; 33(11):8353-8365. PubMed ID: 37195431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Nobarani S; Alaei-Shahmiri F; Aghili R; Malek M; Poustchi H; Lahouti M; Khamseh ME
    Dig Dis Sci; 2022 Apr; 67(4):1389-1398. PubMed ID: 33788095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic.
    Dvorak K; Hainer R; Petrtyl J; Zeman M; Vareka T; Zak A; Sroubkova R; Svestka T; Vitek L; Bruha R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):442-8. PubMed ID: 25004910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of quantitative ultrasound in community screening for hepatic steatosis.
    Chang TY; Chang SH; Lin YH; Ho WC; Wang CY; Jeng WJ; Wan YL; Tsui PH
    Ultrasonics; 2021 Mar; 111():106329. PubMed ID: 33338730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
    PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
    Chen N; Zhou J; Wang K; Li X; Li Z
    BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
    Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.
    Semmler G; Balcar L; Wernly S; Völkerer A; Semmler L; Hauptmann L; Wernly B; Aigner E; Niederseer D; Datz C
    Front Endocrinol (Lausanne); 2023; 14():1244405. PubMed ID: 37842290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Diabetic Retinopathy with Midlife Hepatic Steatosis Diagnosed by Elastography and Hepatic Steatosis Index in Type 2 Diabetes in an Indian Population.
    Mandal M; Ghosh S; Roy S; Mandal S; Dasgupta A
    Metab Syndr Relat Disord; 2024 Apr; 22(3):214-221. PubMed ID: 38417047
    [No Abstract]   [Full Text] [Related]  

  • 32. The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients.
    Afolabi BI; Ibitoye BO; Ikem RT; Omisore AD; Idowu BM; Soyoye DO
    J Natl Med Assoc; 2018 Jun; 110(3):256-264. PubMed ID: 29778128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia.
    Mandraffino G; Morace C; Franzè MS; Nassisi V; Sinicropi D; Cinquegrani M; Saitta C; Scoglio R; Marino S; Belvedere A; Cairo V; Lo Gullo A; Scuruchi M; Raimondo G; Squadrito G
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care.
    Morieri ML; Vitturi N; Avogaro A; Targher G; Fadini GP;
    J Endocrinol Invest; 2021 Sep; 44(9):1879-1889. PubMed ID: 33432553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus.
    Gupta A; Anoop S; Ansari IA; Prakash S; Misra A
    Clin Nutr ESPEN; 2021 Dec; 46():519-526. PubMed ID: 34857244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
    Ampuero J; Aller R; Gallego-Durán R; Crespo J; Calleja JL; García-Monzón C; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Albillos A; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Guerra MH; Augustín S; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero Gómez M;
    J Hepatol; 2020 Jul; 73(1):17-25. PubMed ID: 32147361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study.
    Seeberg KA; Hofsø D; Borgeraas H; Grimnes JO; Fatima F; Seeberg LT; Kvan NP; Svanevik M; Hertel JK; Hjelmesæth J
    BMC Gastroenterol; 2022 Nov; 22(1):448. PubMed ID: 36336684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Liver Steatosis Applying a New Score in Subjects from the Brazilian Longitudinal Study of Adult Health.
    Perazzo H; Benseñor I; Mill JG; Pacheco AG; da Fonseca MJM; Griep RH; Lotufo P; Chor D
    J Clin Gastroenterol; 2020 Jan; 54(1):e1-e10. PubMed ID: 29505553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
    Draijer LG; Feddouli S; Bohte AE; Vd Baan Slootweg O; Pels Rijcken TH; Benninga MA; Stoker J; Koot BGP
    Eur J Pediatr; 2019 Jun; 178(6):863-870. PubMed ID: 30903305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease.
    Kim HN; Jeon HJ; Choi HG; Kwon IS; Rou WS; Lee JE; Lee TH; Kim SH; Lee BS; Shin KS; Lee HJ; Eun HS
    BMC Gastroenterol; 2023 Mar; 23(1):77. PubMed ID: 36932382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.